ANI Pharmaceuticals Expedites Launch With On-Demand Patient Data
ANI Pharmaceuticals Expedites Launch With On-Demand Patient Data
3 Pagesveeva.com 1 CUSTOMER STORY Building on 100 years of success with generics and manufacturing, ANI Pharmaceuticals launched its first patented, branded rare disease therapeutic in January 2022, just 75 days after receiving FDA approval on its supplemental new drug application (sNDA) in November 2021. That meant that within weeks, the company needed to fully understand the patient journey, potential prescribers and treatment patterns, and market landscape—and enable the field with insights from each. ANI Pharmaceuticals Expedites Launch With On-Demand Patient Data CUSTOMER STORY ANI PHARMACEUTICALS Headquarters: Baudette, Minnesota Company Size: Small Pharma Featured Solutions: • Veeva Compass • Veeva Commercial Cloud • Veeva Business Consulting • Veeva Data Cloud HIGHLIGHTS Enter
